Antibody News and Research

RSS

An antibody is a blood protein that is produced in response to and counteracts an antigen. Antibodies are produced in response to disease and help the body fight against the particular disease. In this way, antibodies help the body develop an immunity to disease.

SARS-CoV-2 can make itself unrecognizable to immune response by T-killer cells through mutations

The body's immune response plays a crucial role in the course of a SARS-CoV-2 infection. In addition to antibodies, the so-called T-killer cells, are also responsible for detecting viruses in the body and eliminating them.

5 Mar 2021

Study shows causal relationship between neonatal antibody production and mother's microbiota

A healthy system of gut bacteria, or microbiota, is crucial to health: Gut bacteria not only aid with digestion, but also play an important role in the body's immune response. Infants, however, are not born with full-fledged gut microbiota, which makes it difficult for them to fight off intestinal infections.

4 Mar 2021

Study shows how antibodies fight Zika virus

Zika outbreaks are still having lasting effects on children whose mothers were infected with the Zika virus during their pregnancy.

26 Feb 2021

New gel electrophoresis method allows rapid diagnosis of biomarkers by mass spectrometry

Polyacrylamide gel electrophoresis is a technique that allows high-resolution isolation of proteins separated from biological specimens.

22 Feb 2021

Genes could help determine the intensity of neutralizing antibodies to COVID-19 virus

While neutralizing antibodies form in less than two weeks of a COVID-19 infection, their intensity and durability can differ from one individual to another.

22 Feb 2021

Study reveals novel antibody binding implicated in liver and breast cancer

In the field of structural biology, certain molecules are so uncommon that they can only be captured with a special set of tools.

18 Feb 2021

Electrochemical sensor for rapid detection of multiple sepsis biomarkers in whole blood

Many life-threatening medical conditions, such as sepsis, which is triggered by blood-borne pathogens, cannot be detected accurately and quickly enough to initiate the right course of treatment.

15 Feb 2021

Study suggests the need to characterize patient-specific responses to respiratory syncytial virus

Researchers at Baylor College of Medicine found that while most individuals responded to respiratory syncytial virus (RSV) natural reinfection with a typical sustained antibody response associated with protection, a few individuals surprisingly responded atypically, not being able to sustain the antibody response, which declined to levels that made the individuals susceptible to RSV reinfection.

5 Feb 2021

New technology could improve antibody testing in a broad range of diseases

A global team of researchers has developed a new strategy for fast and reliable antibody tests, which can quantify the immune response induced by vaccination and reveal the timeline and stage of pathogen infection.

5 Feb 2021

Researchers propose new technique to detect SARS-CoV-2

SARS-CoV-2 infects human beings by attaching its surface-exposed spike proteins to ACE2 receptors, which in turn, are exposed on the cell membranes.

5 Feb 2021

Vaccine based on virus-like particle could generate antibodies to prevent malaria

An inexpensive, long-lasting and easy-to-administer vaccine against malaria could be a game-changer for millions of people living in countries where the mosquito-borne disease is endemic.

5 Feb 2021

Genome architectural changes linked to B cell-related blood cancers

Flaws in the way chromosomes are packed into antibody-producing B-cells seem to play a key role in the development of B-cell-related blood cancers.

2 Feb 2021

Targeting glycoprotein could improve response to immune checkpoint therapy

It was an unexpected discovery that started with an analysis of more than 1,000 genes. The question: why game-changing cancer immunotherapy treatments work for only a fraction of patients.

29 Jan 2021

Single-dose universal vaccine could protect against many types of leptospirosis bacteria

Scientists have designed a single-dose universal vaccine that could protect against the many forms of leptospirosis bacteria, according to a study published today in eLife.

27 Jan 2021

Continuous in vitro monitoring could lead to faster, more effective treatments for chronic conditions

A world-first discovery by researchers at Monash University and The University of Queensland could lead to faster and more effective treatments for chronic health complications, such as cardiovascular disease and cancer, with 'fluorescent' in vivo biosensors.

27 Jan 2021

Non-steroidal anti-inflammatory drugs reduce antibody and inflammatory responses to COVID-19

According to a new study, non-steroidal anti-inflammatory drugs (NSAIDs) decreased both inflammatory and antibody responses to SARS-CoV-2 infection in mice.

26 Jan 2021

Immunity of COVID-19 patients may rely on antibodies from previous coronavirus infections

The results of a study led by Northern Arizona University and the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, suggest the immune systems of people infected with COVID-19 may rely on antibodies created during infections from earlier coronaviruses to help fight the disease.

22 Jan 2021

Antibody News and Research

Further Reading

SARS-CoV-2 can make itself unrecognizable to immune response by T-killer cells through mutations

Study shows causal relationship between neonatal antibody production and mother's microbiota

Study shows how antibodies fight Zika virus

New gel electrophoresis method allows rapid diagnosis of biomarkers by mass spectrometry

Genes could help determine the intensity of neutralizing antibodies to COVID-19 virus

Study reveals novel antibody binding implicated in liver and breast cancer

Electrochemical sensor for rapid detection of multiple sepsis biomarkers in whole blood

Study suggests the need to characterize patient-specific responses to respiratory syncytial virus

New technology could improve antibody testing in a broad range of diseases

Researchers propose new technique to detect SARS-CoV-2

Vaccine based on virus-like particle could generate antibodies to prevent malaria

Genome architectural changes linked to B cell-related blood cancers

Targeting glycoprotein could improve response to immune checkpoint therapy

Single-dose universal vaccine could protect against many types of leptospirosis bacteria

Continuous in vitro monitoring could lead to faster, more effective treatments for chronic conditions

Non-steroidal anti-inflammatory drugs reduce antibody and inflammatory responses to COVID-19

Immunity of COVID-19 patients may rely on antibodies from previous coronavirus infections

COVID-19 virus triggers antibody response from prior coronavirus infections

Scientists identify the sensor in human lungs that detects SARS-CoV-2

Nanobodies can prevent entry of SARS-CoV-2 coronavirus into human cells

Antibodies eBook

Driving Support for Pharmaceutical Testing Through Continuous Innovation

From Memory to Metaplasticity: Unraveling the Brain's Secrets

Revolutionizing Mass Spectrometry: A Deep Dive into Plasmion’s SICRIT® Technology

Latest in Genomics